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Scope: The Phenol-Explorer web database details 383 polyphenol metabolites identified in
human and animal biofluids from 221 publications. Here, we exploit these data to characterize
and visualize the polyphenol metabolome, the set of all metabolites derived from phenolic food
components.
Methods and results: Qualitative and quantitative data on 383 polyphenol metabolites as de-
scribed in 424 human and animal intervention studies were systematically analyzed. Of these
metabolites, 301 were identified without prior enzymatic hydrolysis of biofluids, and included
glucuronide and sulfate esters, glycosides, aglycones, and O-methyl ethers. Around one-third
of these compounds are also known as food constituents and corresponded to polyphenols
absorbed without further metabolism. Many ring-cleavage metabolites formed by gut micro-
biota were noted, mostly derived from hydroxycinnamates, flavanols, and flavonols. Median
maximumplasma concentrations (Cmax) of all humanmetabolites were 0.09 and 0.32Mwhen
consumed from foods or dietary supplements, respectively. Median time to reach maximum
plasma concentration in humans (Tmax) was 2.18 h.
Conclusion: These data show the complexity of the polyphenol metabolome and the need to
take into account biotransformations to understand in vivo bioactivities and the role of dietary
polyphenols in health and disease.
Keywords:
Bioavailability / Intervention studies / Metabolism / Pharmacokinetics / Polyphenol
metabolome / Pure polyphenol doses
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
Polyphenols are a large and complex class of bioactive plant
compounds. Around 500 are known to be consumed from
human diets, and the compounds are further divided into
numerous classes and subclasses according to their carbon
skeleton [1] (Supporting Information 1). The average total in-
take of polyphenols per person in Western populations could
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Abbreviations: Cmax, maximumplasma concentration; Tmax, time
to reach maximum plasma concentration
be as high as 2 g/day [2]. Polyphenol consumption may pro-
tect against cardiovascular diseases, cancers, and a range of
other diseases [3, 4]. As a result, the last 15 years has seen
the accumulation of an expansive body of literature on their
occurrence, metabolism, bioactivities, and bioavailability.
The total set of polyphenols or polyphenol metabolites
present in foods or in human biospecimens is termed the
“polyphenolmetabolome” [5]. Circulatingmetabolites are un-
likely to be the same compounds as ingested polyphenols, but
derivatives formed either by endogenous metabolism or by
the microbiota, which allow effective transport and elimina-
tion from the body. Many of these metabolites have been
identified in human and animal biofluids from controlled
intervention studies with polyphenol-rich foods or pure
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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polyphenols. All metabolites described in the literature have
been extracted and stored in Phenol-Explorer, a web database
originally conceived as a repository of polyphenol food com-
position data [6, 7]. The database enables the retrieval of all
known polyphenol metabolites formed upon uptake of a par-
ticular food or polyphenol with accompanying pharmacoki-
netic data, if available. Until the release of this database, the
identities of polyphenol metabolites were scattered through-
out a large volume of literature and frequently difficult to
obtain.
Previous studies have reviewed polyphenol absorption and
metabolism from controlled intervention studies, taking into
account the dose size and mode of administration [8, 9]. In-
stead, the aim of this study is to exploit all Phenol-Explorer
data to systematically analyze the polyphenol metabolome
and, more specifically, the nature of the metabolites reported
in intervention studies and their pharmacokinetic properties.
Polyphenolmetabolites are distributed to tissues andmay act,
e.g., by modulating signaling cascades, which govern biolog-
ical processes, such as endothelial function [10] and cell-cycle
control [11]. Thus a notable use of the database might be to
find out which metabolites circulate after administration of a
given polyphenol-rich source that is suspected of imparting
beneficial effects upon health [12]. Qualitative and pharma-
cokinetic knowledge of the polyphenol metabolome has also
been essential for the identification of biomarkers of polyphe-
nol intake in metabolomic studies [13].
2 Materials and methods
2.1 Sources of data on polyphenol metabolism
and pharmacokinetics
All polyphenol intervention studies in the Phenol-Explorer
database were included in the analysis [7]. Publications were
required tomeet the following base criteria: (i) be intervention
studies using a single or repeated orally administered dose
of a normal food source, an experimental food (e.g., food ex-
tract, dried, and powdered foods) or an oral supplement; (ii)
be conducted in vivo on disease-free humans or animals; (iii)
use an appropriate analytical technique capable of reliably
identifying metabolites; (iv) detect or quantify at least one
polyphenol metabolite in urine or plasma. In brief, separate
“interventions” were identified from each publication, where
one intervention was defined as the administration of a given
dose of polyphenol source (or control) to a single species,
with subsequent collection of biofluids. Study design details
for each intervention were entered into the database followed
by the identities of metabolites corresponding to each inter-
vention, along with any pharmacokinetic details.
2.2 Data analysis
Phenol-Explorer tables on metabolites detected, metabo-
lite concentrations, plasma pharmacokinetics, and
urine pharmacokinetics were exported and data ana-
lyzed using Microsoft Excel and R statistical software
(http://www.R-project.org/). Chemical similarities, based on
Tanimoto scores, were calculated for each pair of Phenol-
Explorer metabolites using the PubChem structure cluster-
ing tool. The MetaMapp tool (http://metamapp.fiehnlab.
ucdavis.edu) was used to format and filter the PubChem
similarity output matrix, associating only pairs of metabolites
with similarity scores >0.7 [14]. The matrix was mapped
to a network graph using Cytoscape open-source software
[15]. The metabolic transformations of pure compounds
administered to humans and animals were visualized using
Circos open-source software [16].
3 Results
3.1 Polyphenol intervention studies
Data originate from 221 publications describing interven-
tion studies with polyphenol-rich sources. These publications
produced 424 separate interventions, of which 398 were on
humans or rats. Polyphenol sources were regular and “ex-
perimental” foods and included raw foods, processed foods,
and food extracts. In addition, pure polyphenol doses were
also administered in solution or in powder, tablet, or capsule
form. Flavonoids were most studied overall, particularly the
flavanones and anthocyanins. Foods and experimental foods
weremost commonly administered to humans, whereas pure
compounds most commonly administered to rats. Doses
were either given once or at time intervals, where interven-
tion duration varied from a few hours to several months. The
range of study designs is summarized in Table 1.
3.2 Diversity of polyphenol metabolites
A total of 383 polyphenol metabolites identified in blood or
urinewere compiled from the literature as part of the polyphe-
nol metabolome. Similar numbers of metabolites were
reported in human and rat studies, with 104 metabolites
common to both species (Fig. 1A). Fewer metabolites were
reported only in plasma than only in urine, and around half
were identified in both biofluids (Fig. 1B). Most metabo-
lites (n = 301) were identified without prior hydrolysis of
the glucuronides and sulfate esters with enzymes (Fig. 1C).
These included 53 glucuronides and 23 sulfate esters as well
as 67 glycosides (Supporting Information 2). Anthocyanin
glycosides accounted for most of glycoside conjugates. The
remaining metabolites were aglycones or esters. Of the 301
metabolites identified in biofluidswithout prior enzyme treat-
ment, 114 were known as food components (out of the 502
known food polyphenols in Phenol-Explorer) (Fig. 1D). The
latter correspond to compounds absorbed in the body without
further biotransformation. The remaining 187 metabolites
correspond to methylated derivatives and other metabolites
formed in host tissues or by microbiota.
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Table 1. Polyphenol intervention study design
Number of intervention studies
Human Rat Othera) Total
Polyphenol subclass studied
Anthocyanins 35 22 5 62
Flavanols 40 32 6 78
Flavanones 31 12 2 45
Flavonols 20 9 0 29
Hydroxybenzoic acids 24 13 4 41
Hydroxycinnamic acids 4 19 0 23
Isoflavones 38 13 2 53
Lignans 8 22 2 32
Stilbenes 25 3 5 33
Tyrosols 18 10 0 28
Duration
Less than 12 h 42 22 5 69
12–24 h inclusive 115 58 7 180
2–7 days inclusive 41 21 1 63
1 month or more 45 54 13 112
Dose type
Experimental food 101 49 12 162
Food 108 19 3 130
Pure compound 34 87 11 132
Repeated dose
No 191 112 17 320
Yes 52 43 9 104
Four hundred twenty-four separate interventions were included,
originating from 221 publications.
a) Other animal models used were mouse, pig, dog, and
sheep. All references used can be obtained from http://www.
phenol-explorer.eu.
Mapping of the polyphenol metabolome by chemical
similarity revealed distinct clusters of related metabolites
(Fig. 2). The largest cluster, in the central part of the chem-
ical similarity map, contains glucuronides of all polyphenol
classes and subclasses, as well as some glycosides. The an-
thocyanins (mono- and diglycosides) are chemically distinct
from all other metabolites and account for the next largest
cluster. Hydroxycinnamic acids and benzoic acids are seen
clustered at the bottom and middle and left. Compounds
found only in biofluids and those also known as food compo-
nents are indicated by red and green nodes, respectively. The
former includes glucuronides, sulfate esters, O-methylated
compounds (e.g. 3′-O-methylepicatechin, and O-methylated
anthocyanins in the center of the anthocyanin cluster) and
microbial metabolites (such as dihydrogenated isoflavones
and hydroxycinnamic acids, hippuric acid, and urolithin C).
The most commonly reported metabolites are emphasized
with nodes sizes proportional to the number of interventions
in which they were identified. See Supporting Information 3
for full metabolite labels.
3.3 Pharmacokinetics
Of the 383 metabolites in Phenol-Explorer, 235 were quan-
tified in biofluids at multiple time points and pharmacoki-
Figure 1. Venn representation of the polyphenol metabolome as
described by Phenol-Explorer (n= 383). (A)Metabolites identified
in human (H) or rat (R) biofluids (other animal models omitted).
(B) Metabolites from all species identified in urine (U) or plasma
(P). (C) Metabolites identified without (N) or after (Y) hydrolysis of
biospecimens. (D) Phenolic food components (FC) or metabolites
(M) formed in humans or experimental animals.
netics described. A total of 222 maximum plasma concen-
tration (Cmax) values were collected for 88 metabolites. In
humans, a median Cmax of 0.1 M (interquartile range =
0.37 M) was observed after food or dietary supplement con-
sumption. Stratification of this distribution by dose type re-
vealed a shifted distribution of values for pure compounds
compared to foods (median values of 0.32 and 0.09 M, re-
spectively; Fig. 3A). In rats, where pure polyphenols were
more often administered, higher maximum concentrations
were achieved (median= 0.41M, interquartile range= 2.25
M). In relation to time taken to reachmaximumplasma con-
centration (Tmax), 207 values were collected corresponding to
81 metabolites. Median Tmax was much shorter in rat than
in human (median time = 0.71 versus 2.18 h). In rat, peak
concentrations usually occurred within 1 h of polyphenol ad-
ministration and few values >5 h were observed (Fig. 3B).
In humans, Tmax of flavanone and isoflavone metabolites was
usually in excess of 5 h (Fig. 3C). For most other subclasses,
Tmax was usually less than 2 h. Seventy-one plasma half-life
values were compiled for the Phenol-Explorer database. Me-
dian half-life for all polyphenol metabolites in humans was
2.8 h (interquartile range = 4.05 h).
The proportion of dose excreted in urine was measured
for 80 compounds until 24 h or more after administration.
For extracts incubated with either -glucuronidase or sulfa-
tase to group all conjugates with a common parent polyphe-
nol, proportion of dose recovered could be used as a mea-
sure of overall bioavailability. Median urinary excretion was
10.9%, although this varied substantially between different
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Figure 2. Chemical similarity map of the polyphenol metabolome showing the names of the most frequently detected polyphenol metabo-
lites from 221 publications. Node and label size are proportional to the number of intervention studies in which each metabolite has
been reported in biofluids. Similar compounds (Tanimoto chemical similarity >70%) are linked by gray edges. Red nodes correspond to
metabolites that have been detected only in biofluids. Green nodes correspond to metabolites that have been detected in biofluids and are
also food components.
polyphenols (interquartile range = 25.9%) (Supporting In-
formation 4). Some were particularly poorly recovered (e.g.
0.01% for some anthocyanins) either due to poor absorption
in the gut or to extensive biotransformation. The highest re-
coveries in humans were observed for stilbenes, tyrosols, and
isoflavonoids (20–60%).
3.4 Frequently reported metabolites from
polyphenol-rich and pure polyphenol doses
The most frequently identified metabolites (without enzyme
treatment of biofluids) in Phenol-Explorer were determined
based on the number of intervention studies in which each
was described (Table 2). For many of these, food sources
are available in Phenol-Explorer as well as the identities
of precursors administered as pure compounds. The most
commonly reported metabolite was cyanidin 3-O-glucoside,
which appeared in plasma in 40 different interventions after
administration of different berries, berry extracts, and pure
cyanidin 3-O-glucoside. Delphinidin and peonidin glucosides
were also commonly reported in these interventions. From
the flavanol subclass, epicatechin and 3-O-methylepicatechin
were frequently observed in biofluids, usually after exper-
imental doses of cocoa and tea. The most frequently ob-
served glucuronideswere those of hesperetin andnaringenin,
usually originating from citrus fruits. The phenolic acids 4-
hydroxybenzoic acid, 4-hydroxyphenylacetic acid, gallic acid,
and the most downstream polyphenol metabolite, hippuric
acid, were frequently identified as metabolites of a diverse
range of polyphenols.
Administration of 59 pure polyphenol doses, mostly to
rats, led to the identification of 160 different metabolites in
biofluids. Doses of 5-caffeoylquinic acid, which is particularly
well studied as a major coffee phenol, led to the identification
of 27 circulating metabolites across all studies, while caffeic
acid and epicatechin were each the precursor of 22 deriva-
tives. Over half of all metabolites identified in biofluids in
interventions with pure polyphenols were, however, derived
from a single precursor only. The metabolism of these pure
polyphenol doses is represented in Fig. 4.
4 Discussion
Biological databases are essential for the efficient retrieval
of relevant information from large numbers of scien-
tific publications [17]. In the present study, all polyphenol
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Figure 3. Summary of polyphenol pharmacokinetics. (A) Empiri-
cal cumulative density function showing distribution of Cmax val-
ues collected. Bold and normal lines represent human and rat
data, respectively; solid and dashed lines represent foods (includ-
ing experimental foods) and pure compound doses, respectively.
(B) Frequency polygon of Tmax values. Bold and normal lines
represent human and rat data, respectively. (C) Variation of Tmax
with polyphenol subclass and species (circles, human; triangles,
rat).
metabolites reliably identified in human and animal bioflu-
ids and described in literature were collated and regarded as
the experimentally determined polyphenolmetabolome. This
is only a small subset of all metabolites theoretically possible,
since coverage is governed by research design and analyti-
cal capabilities. For example, less glucuronides and sulfates
andmore aglycones and esters were described in intervention
studies included in Phenol-Explorer than might be expected.
Conjugates are indeed difficult to identify and the metabo-
lites whose position of conjugation were unknown were not
included in Phenol-Explorer. Also, a striking number of un-
changed glycosides were found in biofluids; most were an-
thocyanins, recovered in low concentrations, which escaped
deglycosylation by luminal enzymes and can be transported
into cells by bilitranslocasemembrane proteins [18,19]. In ad-
dition, several glycosides of other polyphenol subclasses were
either detected and quantified (hesperidin, naringin, neohes-
peridin, puerarin, and quercetin 3-O-rutinoside) or detected
only (6′ ′-O-malonyldaidzin, daidzin, glycitin, isorhamnetin
3-O-glucoside, quercetin 3,4′-O-diglucoside, quercetin 3,4′-
O-diglucoside, and quercetin 3-O-glucoside) in biofluids of at
least one volunteer or animal study.
Absorption and pharmacokinetics govern the extent to
which polyphenols reach target tissues via systemic circula-
tion. Phenol-Explorer data show that plasma concentrations
> 10 M are possible but implausible from human diets,
and typical plasma concentrations of individual polyphenol
metabolites are many times lower (Fig. 3A). The greatest
Cmax recorded in humans from an unmodified food was
3.95 M quercetin from a dose of shallot skin [20], although
the consumption of this tissue alone is improbable. The high-
est Cmax recorded for a polyphenol following a dose of any
commonly-consumed food tested was 1.21 M dihydrofer-
ulic acid following intake of instant coffee (4 g instant coffee
powder in hot water) [21]. In both cases, glucuronides and sul-
fate esters were hydrolyzed before analysis. However, overall
high levels of polyphenol exposure may be experienced upon
the simultaneous consumption of different polyphenol-rich
foods containing many different polyphenols. Upon inges-
tion of such a meal, total polyphenol plasma concentrations
in excess of 5 M might be possible. Time taken to reach
these peak concentrations is also important, since metabo-
lites which are absorbed gradually and persist in circulation
may be more likely to reach target tissues. Tmax values col-
lected for Phenol-Explorer clustered at around 2 h and 5 h af-
ter polyphenol doses in humans, corresponding to absorption
in the small and large intestine, respectively. In rat models,
small intestine absorption was quicker than in humans and
late Tmax was less frequently observed. Care should be taken
when extrapolating pharmacokinetic data from rat models
to human metabolism, particularly as metabolizing enzymes
show different expression profiles [22].
Some polyphenol metabolites were identified in many
different interventions. Cyanidin 3-glucoside was detected
in the most, identified in 40 separate intervention stud-
ies following ingestion of many different berries and berry
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
208 J. A. Rothwell et al. Mol. Nutr. Food Res. 2016, 60, 203–211
Ta
b
le
2.
T
h
e
25
m
o
st
co
m
m
o
n
ly
id
en
ti
fi
ed
p
o
ly
p
h
en
o
lm
et
ab
o
lit
es
in
h
u
m
an
an
d
an
im
al
b
io
fl
u
id
s
ac
ro
ss
42
4
in
te
rv
en
ti
o
n
st
u
d
ie
s
fr
o
m
22
1
p
u
b
lic
at
io
n
s
Po
ly
p
h
en
o
lm
et
ab
o
lit
e
(p
o
ly
p
h
en
o
ls
u
b
cl
as
s)
N
u
m
b
er
o
f
in
te
rv
en
ti
o
n
s
in
w
h
ic
h
d
et
ec
te
d
(n
u
m
b
er
o
f
ex
p
er
im
en
ta
ls
o
u
rc
es
)a
M
ai
n
fo
o
d
d
o
se
s
Pu
re
co
m
p
o
u
n
d
d
o
se
s
H
ig
h
es
t
C
m
ax
(
M
)b
),
c)
T
m
ax
va
lu
e
o
r
ra
n
g
e
(h
)b
),
c)
H
u
m
an
R
at
H
u
m
an
R
at
C
ya
n
id
in
3-
O
-g
lu
co
si
d
e
(a
n
th
o
cy
an
in
)
40
(3
4)
Va
ri
o
u
s
b
er
ri
es
,b
er
ry
ju
ic
es
an
d
ex
tr
ac
ts
C
ya
n
id
in
3-
O
-g
lu
co
si
d
e
0.
04
0.
3
1.
09
0.
25
H
ip
p
u
ri
c
ac
id
(n
o
n
p
h
en
o
lic
m
et
ab
o
lit
e)
23
(1
9)
C
ra
n
b
er
ry
p
o
w
d
er
,g
re
en
te
a
an
d
g
re
en
te
a
so
lid
s,
w
h
ea
t
b
ra
n
,p
o
p
la
r
w
o
o
d
lig
n
in
s,
o
ra
n
g
e
ju
ic
e,
b
la
ck
cu
rr
an
t
an
d
ra
sp
b
er
ry
ju
ic
es
C
at
ec
h
in
,f
er
u
lic
ac
id
,s
in
ap
ic
ac
id
—
—
—
—
(−
)-
E
p
ic
at
ec
h
in
(fl
av
an
o
l)
16
(7
)
G
re
en
te
a,
co
co
a
p
o
w
d
er
(−
)-
E
p
ic
at
ec
h
in
,p
ro
cy
an
id
in
B
2
—
0.
25
—
0.
5
R
es
ve
ra
tr
o
l,
ci
s
o
r
tr
an
s
(s
ti
lb
en
e)
16
(3
)
R
ed
w
in
e,
Po
ly
g
o
n
u
m
cu
sp
id
at
u
m
ex
tr
ac
t
R
es
ve
ra
tr
o
l
2.
36
0.
86
–1
.5
0
—
3′
-O
-M
et
hy
le
p
ic
at
ec
h
in
(fl
av
an
o
l)
15
(5
)
C
o
co
a
p
o
w
d
er
(−
)-
E
p
ic
at
ec
h
in
,p
ro
cy
an
id
in
B
2
—
0.
55
—
0.
5–
1.
5
4-
H
yd
ro
xy
b
en
zo
ic
ac
id
(h
yd
ro
xy
b
en
zo
ic
ac
id
)
15
(1
2)
G
re
en
te
a,
cr
an
b
er
ry
p
o
w
d
er
,r
as
p
b
er
ry
an
d
o
ra
n
g
e
ju
ic
es
,v
ir
g
in
o
liv
e
o
il,
b
lu
eb
er
ry
Pe
la
rg
o
n
id
in
—
—
—
—
D
el
p
h
in
id
in
3-
O
-g
lu
co
si
d
e
(a
n
th
o
cy
an
in
)
15
(1
4)
B
er
ri
es
an
d
b
er
ry
ex
tr
ac
ts
,b
lo
o
d
o
ra
n
g
e
ju
ic
e
D
el
p
h
in
id
in
3-
O
-g
lu
co
si
d
e
—
0.
15
—
0.
25
–5
.0
0
C
ya
n
id
in
3-
O
-r
u
ti
n
o
si
d
e
(a
n
th
o
cy
an
in
)
14
(1
4)
B
er
ri
es
an
d
b
er
ry
ex
tr
ac
ts
,b
la
ck
cu
rr
an
t
an
d
ra
sp
b
er
ry
ju
ic
es
—
0.
04
0.
23
1.
64
0.
25
–1
.0
0
Fe
ru
lic
ac
id
(h
yd
ro
xy
ci
n
n
am
ic
ac
id
)
14
(1
1)
Pe
ri
lla
ex
tr
ac
t,
cr
an
b
er
ry
p
o
w
d
er
,g
re
en
co
ff
ee
ex
tr
ac
t,
cr
an
b
er
ry
an
d
ra
sp
b
er
ry
ju
ic
es
C
af
fe
ic
ac
id
,d
ih
yd
ro
ca
ff
ei
c
ac
id
,f
er
u
lic
ac
id
0.
12
–0
.3
6
1.
68
0.
5–
1.
0
0.
5
Pe
o
n
id
in
3-
O
-g
lu
co
si
d
e
(a
n
th
o
cy
an
in
)
14
(1
3)
B
er
ri
es
an
d
b
er
ry
ex
tr
ac
ts
,c
ra
n
b
er
ry
an
d
ra
sp
b
er
ry
ju
ic
es
C
ya
n
id
in
3-
O
-g
lu
co
si
d
e
0.
00
08
1.
4
0.
05
0.
25
4-
H
yd
ro
xy
p
h
en
yl
ac
et
ic
ac
id
(h
yd
ro
xy
p
h
en
yl
ac
et
ic
ac
id
)
12
(9
)
C
ra
n
b
er
ry
p
o
w
d
er
,c
ra
n
b
er
ry
,o
ra
n
g
e
an
d
ra
sp
b
er
ry
ju
ic
es
,g
re
en
te
a
—
—
—
—
D
ai
d
ze
in
(i
so
fl
av
o
n
e)
12
(1
1)
S
o
y
p
ro
te
in
,s
o
y
b
ev
er
ag
es
,s
o
y
m
ilk
an
d
su
p
p
le
m
en
ts
D
ai
d
ze
in
2.
54
—
1.
0–
9.
1
—
Pe
la
rg
o
n
id
in
3-
O
-g
lu
co
si
d
e
(a
n
th
o
cy
an
in
)
12
(6
)
S
tr
aw
b
er
ry
,m
ar
io
n
b
er
ry
p
o
w
d
er
—
—
—
—
—
N
ar
in
g
en
in
7-
O
-g
lu
cu
ro
n
id
e
(fl
av
an
o
n
e)
11
(8
)
O
ra
n
g
e
an
d
g
ra
p
ef
ru
it
ju
ic
es
,o
ra
n
g
e
N
ar
in
g
en
in
0.
77
—
1.
63
–6
.4
0
—
C
ya
n
id
in
3-
O
-g
al
ac
to
si
d
e
(a
n
th
o
cy
an
in
)
10
(1
0)
B
lu
eb
er
ry
,l
in
g
o
n
b
er
ry
,c
ra
n
b
er
ry
ju
ic
e,
o
th
er
b
er
ry
ex
tr
ac
ts
—
0.
02
0.
19
2.
5
0.
25
G
al
lic
ac
id
(h
yd
ro
xy
b
en
zo
ic
ac
id
)
10
(8
)
C
ra
n
b
er
ry
p
o
w
d
er
,S
h
u
an
g
d
an
g
ra
n
u
le
s,
g
re
en
te
a,
b
lu
eb
er
ry
E
th
yl
ga
lla
te
—
1.
03
—
0.
2
H
es
p
er
et
in
7-
O
-g
lu
cu
ro
n
id
e
(fl
av
an
o
n
e)
10
(7
)
O
ra
n
g
e,
o
ra
n
g
e
ju
ic
e,
p
o
ly
p
h
en
o
l-
ri
ch
d
ri
n
k
H
es
p
er
id
in
1.
48
—
4.
6–
7.
3
—
N
ar
in
g
en
in
4′
-O
-g
lu
cu
ro
n
id
e
(fl
av
an
o
n
e)
10
(7
)
O
ra
n
g
e
an
d
g
ra
p
ef
ru
it
ju
ic
es
,o
ra
n
g
e
—
0.
77
—
1.
63
–6
.4
0
—
Q
u
er
ce
ti
n
(fl
av
o
n
o
l)
10
(9
)
W
h
it
e
w
in
e,
g
in
kg
o
b
ilo
b
a
ta
b
le
t,
b
la
ck
cu
rr
an
t
ju
ic
e,
ye
llo
w
an
d
re
d
o
n
io
n
s,
sh
al
lo
ts
Q
u
er
ce
ti
n
,q
u
er
ce
ti
n
3-
O
-g
lu
co
si
d
e,
q
u
er
ce
ti
n
4′
-O
-g
lu
co
si
d
e
0.
05
,3
.9
5
—
2.
33
–3
.6
0
—
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
Mol. Nutr. Food Res. 2016, 60, 203–211 209
Ta
b
le
2.
C
o
n
ti
n
u
ed
Po
ly
p
h
en
o
lm
et
ab
o
lit
e
(p
o
ly
p
h
en
o
ls
u
b
cl
as
s)
N
u
m
b
er
o
f
in
te
rv
en
ti
o
n
s
in
w
h
ic
h
d
et
ec
te
d
(n
u
m
b
er
o
f
ex
p
er
im
en
ta
ls
o
u
rc
es
)a
M
ai
n
fo
o
d
d
o
se
s
Pu
re
co
m
p
o
u
n
d
d
o
se
s
H
ig
h
es
t
C
m
ax
(
M
)b
),
c)
T
m
ax
va
lu
e
o
r
ra
n
g
e
(h
)b
),
c)
H
u
m
an
R
at
H
u
m
an
R
at
3-
H
yd
ro
xy
p
h
en
yl
ac
et
ic
ac
id
9
(7
)
C
ra
n
b
er
ry
p
o
w
d
er
,o
ra
n
g
e
ju
ic
e
fo
rt
ifi
ed
w
it
h
h
es
p
er
et
in
,c
ra
n
b
er
ry
ju
ic
e
fo
rt
ifi
ed
w
it
h
ru
ti
n
—
—
—
—
C
af
fe
ic
ac
id
(h
yd
ro
xy
ci
n
n
am
ic
ac
id
)
9
(6
)
C
ra
n
b
er
ry
p
o
w
d
er
,s
h
u
an
g
d
an
g
ra
n
u
le
s
C
af
fe
ic
ac
id
,e
ri
o
ci
tr
in
0.
09
—
1.
5–
3.
0
—
G
en
is
te
in
9
(8
)
S
o
y
p
ro
te
in
,s
o
y
m
ilk
,s
o
y
p
ro
te
in
b
ev
er
ag
e,
so
y
su
p
p
le
m
en
ts
1.
02
0.
48
1.
0–
5.
9
0.
5
E
lla
g
ic
ac
id
(h
yd
ro
xy
b
en
zo
ic
ac
id
)
9
(9
)
Po
m
eg
ra
n
at
e
ex
tr
ac
t,
ra
sp
b
er
ry
Pu
n
ic
al
ag
in
0.
11
—
0.
65
–2
.5
8
—
R
es
ve
ra
tr
o
l3
-O
-g
lu
cu
ro
n
id
e,
ci
s
o
r
tr
an
s)
(s
ti
lb
en
e)
8
(8
)
R
ed
,w
h
it
e,
an
d
sp
ar
kl
in
g
w
in
e
P
ic
ei
d
0.
16
—
6
—
Va
n
ill
ic
ac
id
(h
yd
ro
xy
b
en
zo
ic
ac
id
)
8
(6
)
C
ra
n
b
er
ry
p
o
w
d
er
,b
la
ck
cu
rr
an
t
ju
ic
e,
co
co
a
p
o
w
d
er
,v
ir
g
in
o
liv
e
o
il
—
—
—
—
—
a)
O
n
ly
in
te
rv
en
ti
o
n
s
th
at
d
id
n
o
t
en
zy
m
at
ic
al
ly
hy
d
ro
ly
ze
b
io
fl
u
id
s
ar
e
co
u
n
te
d
.
b
)
P
h
ar
m
ac
o
ki
n
et
ic
d
at
a
fo
r
ag
ly
co
n
es
re
p
re
se
n
t
al
lc
o
rr
es
p
o
n
d
in
g
co
n
ju
ga
te
s
fo
llo
w
in
g
en
zy
m
at
ic
hy
d
ro
ly
si
s.
c)
P
h
ar
m
ac
o
ki
n
et
ic
d
at
a
ar
e
o
m
itt
ed
w
h
er
e
m
et
ab
o
lit
es
w
er
e
d
er
iv
ed
fr
o
m
se
ve
ra
ld
iff
er
en
t
p
re
cu
rs
o
rs
.
extracts. However, the flavanol aglycones epicatechin and
3-methylepicatechin were detected after administration of
a greater range of polyphenol-rich foodstuffs. Fewer phase
II conjugates were reported in multiple interventions be-
cause their characterization requires greater analytical pre-
cision. Those most often reported were different isoforms
of naringenin and hesperetin glucuronides, which originate
from flavanone glycosides in citrus fruits. Other metabo-
lites were notable for being derived from a wide range of
polyphenols. The ring-cleavagemicrobialmetabolite hippuric
acid was identified in biofluids after the intake of sources
of polyphenols belonging to all most important subclasses
(Fig. 4, compound #20). Previous studies have shown the
compound to increase upon total polyphenol and fruit in-
take [23, 24] and thus excretion has been postulated to re-
flect polyphenol intake. It may also however be derived
from aromatic amino acids [25] and thus is usually ex-
creted in urine at low levels, independently of phenol in-
take. In the present study, hippuric acid was often associ-
ated with its closest precursor 4-hydroxybenzoic acid (Fig. 4,
hydroxybenzoic acids, compound #07), which itself was one
of the most commonly reported metabolites in the database.
This compound, like 3- and 4-hydroxyphenylacetic acids,
is a product of microbial polyphenol metabolism [26, 27]
and could account for substantial proportions of the in-
gested polyphenol doses. This is illustrated by the many
pathways associating more particularly parent hydroxycin-
namates, flavanols, and flavonols with various phenolic acid
metabolites shown in Fig. 4 (hydroxypentanoic acids, hydrox-
ypropanoic acids, hydroxyphenylacetic acids, and hydroxy-
benzoic acids). In particular,many of thesemicrobialmetabo-
lites are formed from various phenolic precursors (see Fig. 4,
grey histograms).
There is much interest in the discovery of biomarkers of
polyphenol-rich food intake or of total or individual polyphe-
nol intake, since reliable estimates of dietary exposure are nec-
essary to better understand the health effects of polyphenols
through epidemiological studies. Biomarkers could measure
polyphenol intake more objectively than dietary question-
naires, which are susceptible to different types of bias [28].
Detailed information on metabolism and pharmacokinetics,
such as is available in Phenol-Explorer, is useful as a starting
point in biomarker discovery but also aids the identification
ofmetabolites, detected in biofluids, which discriminate high
and low consumers of a food of interest. Phenol-Explorer data,
e.g., support the validity of biomarkers, such as naringenin
and hesperetin glucuronides, recently proven to reflect cit-
rus fruit intake reliably [13]. Biomarkers of exposure will be
essential for establishing relationships between polyphenol
intake and disease risk, particularly for diseases such as can-
cer where links are currently poorly characterized [5].
The present study is the first to describe and visual-
ize the polyphenol metabolome as currently known. How-
ever, certain limitations should be kept in mind. First, de-
spite a much deeper understanding of metabolism than
only a few years ago, only a small proportion of the
C© 2015 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Figure 4. Circular diagram of polyphenol
metabolic pathways derived from stud-
ies in which pure compounds were orally
administered to humans and animals.
Compounds are ordered by subclass and
numbered. Filled circles represent pure
compounds administered in intervention
studies and empty triangles represent metabo-
lites found in urine or plasma. Histograms
indicate the numbers of precursors leading to
the formation of each metabolite (scale 0–8
precursors). Link color represents metabolism
reactions as follows: red, methylation; green,
glucuronidation; blue, sulfation; gray, com-
bination of reactions or unchanged from
precursor. See Supporting Information 5 for
compound codes.
possible polyphenol metabolome has been described. In gen-
eral, studies have disproportionately concentrated on theprin-
cipal flavonoid and phenolic acid subclasses, and more stud-
ies on lignans and complex polyphenols, such as proantho-
cyanidin and theaflavin polymers are needed. A lack of de-
tailed knowledge is evident for some commonly consumed
subclasses, such as anthocyanins, which are unstable and
quickly break down to smaller products [29]. As enzymatic
hydrolyses are often employed, relatively few phase II con-
jugates have been confirmed, and these have great poten-
tial as specific biomarkers of intake of individual polyphe-
nols and polyphenol-containing foods. There is evidence that
over 500 polyphenols are known to be consumed by hu-
mans, but in our analysis the administration of only 59 pure
polyphenols to humans or rats led to the identification of 160
polyphenol metabolites. Second, more studies administer-
ing pure compounds are required to precisely identify
metabolites of interest. A particular limitation of the present
analysis is the proportion of pure polyphenol studies per-
formedon animals (98 experimental interventions) compared
to humans (32 interventions). Thus knowledge obtained from
pure polyphenol doses is derived predominantly from ani-
mals. Despite these drawbacks, the knowledge of the polyphe-
nol metabolome summarized here is needed both to under-
stand in vivo bioactivity and to aid in the search for biomarkers
for application to the study of polyphenol intake in relation
to health.
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